Sökning: (WFRF:(Castiglione Monica)) pers:(Goldhirsch Aron) >
Patterns of recurre...
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
-
Pagani, Olivia (författare)
-
Price, Karen N (författare)
-
Gelber, Richard D (författare)
-
visa fler...
-
Castiglione-Gertsch, Monica (författare)
-
- Holmberg, Stig B, 1946 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för kirurgi,Institute of Clinical Sciences, Department of Surgery
-
Lindtner, Jurij (författare)
-
Thürlimann, Beat (författare)
-
Collins, John (författare)
-
Fey, Martin F (författare)
-
Coates, Alan S (författare)
-
Goldhirsch, Aron (författare)
-
visa färre...
-
(creator_code:org_t)
- 2009-01-10
- 2009
- Engelska.
-
Ingår i: Breast cancer research and treatment. - : Springer Science and Business Media LLC. - 1573-7217 .- 0167-6806. ; 117:2, s. 319-24
- Relaterad länk:
-
https://europepmc.or...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The current therapeutic strategy in breast cancer is to identify a target, such as estrogen receptor (ER) status, for tailoring treatments. We investigated the patterns of recurrence with respect to ER status for patients treated in two randomized trials with 25 years' median follow-up. In the ER-negative subpopulations most breast cancer events occurred within the first 5-7 years after randomization, while in the ER-positive subpopulations breast cancer events were spread through 10 years. In the ER-positive subpopulation, 1 year endocrine treatment alone significantly prolonged disease-free survival (DFS) with no additional benefit observed by adding 1 year of chemotherapy. In the small ER-negative subpopulation chemo-endocrine therapy had a significantly better DFS than endocrine alone or no treatment. Despite small numbers of patients, "old-fashioned" treatments, and competing causes of treatment failure, the value of ER status as a target for response to adjuvant treatment is evident through prolonged follow-up.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Pagani, Olivia
-
Price, Karen N
-
Gelber, Richard ...
-
Castiglione-Gert ...
-
Holmberg, Stig B ...
-
Lindtner, Jurij
-
visa fler...
-
Thürlimann, Beat
-
Collins, John
-
Fey, Martin F
-
Coates, Alan S
-
Goldhirsch, Aron
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Breast cancer re ...
- Av lärosätet
-
Göteborgs universitet